NON-SURGICAL EYE REJUVENATION AT DR. ROBERT ZUBOWSKI’S PARAMUS, NJ CENTER

While most respected plastic surgeons will tell you that a blepharoplasty, or cosmetic eyelid surgery, is the gold standard for eye rejuvenation, there are other non-surgical alternatives that, for some patients, provide impressive, long lasting results.

Patients at the Robert Zubowski MD Center for Plastic and Reconstructive Surgery often remark that signs of facial aging are first noticeable around their eyes. Typically, they notice skin becoming thinner and less elastic, descending brows, or perhaps receding or enlarged upper eyelids. Sometimes the bones around the eyes appear more prominent as well. For patients who are beginning to show these early signs but are not ready for eyelid surgery, or for patients who dismiss surgery altogether, injectable fillers and Botox® may be the answer.

At our Paramus, NJ center many of our patients elect to be treated for their aging eyes with certain hyaluronic acid (HA) fillers: Juvéderm® and Restylane®. They both work extremely well in the tear trough area, or hollow under the eyes. We’re also using Botox® to erase crow’s feet, smooth frown lines at the brow, and treat related facial lines.

We’ve been using HA fillers at our Paramus NJ center since 2005, soon after the first one received FDA approval. For an in-depth look at HA fillers as related to improving the look of aging eyes, there’s an interesting article in the August 2009 issue of the Aesthetic Surgery Journal.

Today at the Robert Zubowski MD Center for Plastic and Reconstructive Surgery we are providing total eye rejuvenation which can include a take-home treatment, Latisse®, to give luxurious thicker, longer and darker lashes.

All of the treatments can last up to nine months, and without any downtime or uncomfortable recuperation. They are wildly popular. For more information, or to schedule an appointment, please contact Ann Carbone, our practice manager.

Leave a Reply

Your email address will not be published. Required fields are marked *

Any Questions?

Latest News